Dr Sunil Solomon, MBBS PhD MPH is an Associate Professor of Medicine at the Johns Hopkins University School of Medicine. He also serves as the Chairman of the YR Gaitonde Centre for AIDS Research and Education (YRGCARE), India. He completed his medical training at the Sri Ramachandra Medical University in India and received a Masters in Public Health and a doctorate in Epidemiology from the Johns Hopkins University, US. His research is focused on the epidemiology, clinical management and access to HIV and HCV care among vulnerable populations such as PWID and MSM. He has over 100 peer-reviewed publications and has been elected into the Phi Beta Kappa and Delta Omega honors societies. In 2015, he was one of the first recipients of the Avenir award, a Director’s award from the NIH, USA aimed at identifying individuals who show promise of being tomorrow's leaders in the field of drug abuse and HIV.

Dr Joseph Doyle, Senior Lecturer, Monash University and Alfred Health; Deputy Director, Disease Elimination Program, Burnet Institute, Melbourne, VIC, Australia

Associate Professor Peter Revill is a senior medical scientist at the Victorian Infectious Diseases Reference Laboratory (VIDRL), Royal Melbourne Hospital, located at the Peter Doherty Institute of Infection and Immunity, where he heads the Hepatitis B Molecular Virology laboratory. His interests include elucidating the causes of HBV associated liver cancer.

Jack Wang and Kelvin Muller are both final year medical students at Flinders University. Dr Jane Davies is a clinical researcher with over ten years experience in the area of Global Health and Infectious Diseases. She also works clinically as a consultant in Infectious Diseases at the Royal Darwin Hospital.

Mr Yianni Droungas is a PhD student at the Victorian Infectious Diseases Reference Laboratory, located at the Peter Doherty Institute of Infection and Immunity. His research is focused on the hepatitis B virus, specifically on understanding the steps involved between the Hepatitis B e Antigen and host immune system interactions.

Tanya Applegate leads the research laboratory team in the Viral Hepatitis and Clinical Research Program at the Kirby Institute, UNSW Sydney. Tanya’s interests include HCV translational research, molecular epidemiology and the development and implementation of HCV molecular diagnostics, to improve health care among marginalised populations and resource limited settings.

Dr Mel Kelly is an infectious diseases physician with an interest in HIV and Viral Hepatitis.

Beth Catlett works for St Vincent's Hospital in applied medical research and is a PhD candidate at UNSW. She has a strong interest in novel clinical laboratory diagnostics and there implementation to enable real world HIV and HCV testing within marginalised populations and remote and resource limited settings.

Mary Garcia is Co-Head of The Burnet Institute Global Health Diagnostics Laboratory and has over 20 years experience working in the commercial diagnostic industry. Mary has worked on the development of Hepatitis A, HIV and syphilis rapid point-of care tests and her current project is the ALT rapid test.